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843FO-6 The Neurohumoral and Hemodynamic Effects of Acute 
Vasopeptidase InhlblUon In Experimental Hypertension 
Calin v. Maniu, Donna M. Meyer, Margaret M. Redfield, Mayo C/inic, Rochester, 
Minnesota. 
Background: Vasopeptidase inhibitors (VPt) are a novel class of antihypertensive 
agents which inhibit angiotensin converting enzyme as well as peptideses which degrade 
atrial (ANP) and brain (BNP) natduretic peptides and adrenomedullin (ADM). Whether 
VPI therapy augments these hormones in hypertension (HTN) is unclear. Further, the 
hemodynamic mechanisms whereby VPI lower blood pressure are ill defined. 
Methods: Dogs (n=8) were made hypertensive by renal wrapping (mean arterial pres- 
sure = 171+-10 mm Hg at 4 weeks). After 5-8 weeks of HTN, dogs were instrumented for 
chronic conscious assessment of LV pressure (LVP) and volume (LVV). Two weeks later, 
hemodynamics and hormone levels were assessed before and 30 and 60 minutes after 
acute VPI infusion (omapatrilat, 30 p.M/kg iv). 
Results: Table (* = p<O.05 vs. baseline, # = p<0.05 vs. before renal wrap) Experimental 
HTN resulted in increases in plasma BNP but not ANP and a trend towards increased 
ADM (p=0.15). Acute VPI resulted in marked decreases in systolic and end-diastolic LVP 
and LVV. Acute VPI increased plasma ADM, decreased BNP but had no effect on ANP. 
Conclusions: In experimental HTN profound decreases in preload occur with VPI and 
contribute to the antihypertensive effect. While ANP did not decrease despite a reduction 
in filling pressures, the decrease in LV systolic pressure was associated with a reduction 
in BNP. These data suggest that VPI induced augmentation of ADM rather than natri- 
uretic peptides is contdbutin~ to its antihypertensive effect. 
Before renal wrap Baseline 30 minutes 60 minutes 
Systolic LVP mm Hg 169+_22 111±15" 113+15" 
End-diastolic LVP mm Hg 14+4 4±3" 5+3* 
End-diastolic LVV mL 50±9 39+-7* 40±7* 
ADM pg/mL 21±1 38±10 74±20* 74±16" 
BNP pg/mL 34±7 420~134 # 285±68 234+81" 
ANP pg/mL 108±33 72+~?,3 93_+30 87±27 
1151-70 Heavy and Light Cigarette Smokers Have a Similar 
Dysfunction In NO Biosynthesis: An In Vivo and In Vitro 
Correlation 
Raiat S. Barua. John A. Ambrose, Lesley-Jane Eales-Reynotds, Mary C. DeVoe, John G. 
Zarvas, Dhanonjoy C. Saha, Saint Vincent Catholic Medical Centers of New York, New 
York, The School of Biomedical and Life Sciences, University of Surrey, Guildford, United 
Kingdom. 
Background:. Limited studies suggest that cigaretle smoking may be associated with a 
dose-dependent decrease of endothelium-dependent vasodilatatJon (EDV). This dose 
specific effect on the nitric oxide (NO) biosynthetic pathway is not known. In the current 
study effects of light (_<1 pk/week) and heavy (->1 pk/day) smoking on brachial artery 
reactivity in vivo were directly correlated with the NO biosynthetic pathway in vitro using 
serum from the same individuals. 
Methods: Brachial artery reactivity to flow (endothelium-dependent) and nitroglycerin 
(endothelium-independent) were measured in 8 nonsmokers (NS), 8 heavy smokers 
(HS) and 7 light smokers (LS). Serum from each subject was incubated with confluent 
(-85%) human umbilical endothelial cells (HUVECs) in 24-well tissue-culture plates for 
12 hours. Basal (12 hour) and substance P-stimulated (30 min) NO production was mea- 
sured (chemiluminesence). The HUVECs used for measuring basel NO production were 
lysed and both endothelial nitric oxide synthase (eNOS) protein expression (ELISA) and 
eNOS activity (L-arginine to L-citrulline conversion) were determined. 
Results: EDV was not significantly different between HS and LS (0.1:L~0.1 vs 1.1+1.1%, 
p=0.50) but both were significantly reduced compared to NS (6.0~1.5%, p<0.001). There 
was no difference in nitroglycerin-mediated dilatation between the groups (p=0.34). 
HUVECs treated with HS and LS serum showed similar basal (1137+~67 vs 1418±421 
nM, p=0.70) and stimulated NO production (121+120 vs 145±87 nM, p--O.90), eNOS pro- 
tein expression (974±50 vs 888+-96 pg/ml, p=0.30) and eNOS activity (1.11±0.16 vs 
1.24_+0.19 pmol L-citrulline/min/pg eNOS, p=0.62) but all were significantly different com- 
pared to NS. Serum cotinine level and pack year cigarette exposure both were signifi- 
cantly different between HS and LS (286.+26 vs 140~55 ng/ml, p<0.001; and 13+_3.5 vs 
0.7±0.2 pk/yr, p<0.001, respectively). 
Concluelons: These results indicate that both in vivo and in vitro, light smoking may 
have similar detrimental effects on EDV and NO biosynthetic pathway as does heavy 
smoking. These data may have important implications in determining what amount of cig- 
arette exposure imparts cardiovascular isk. 
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115i-69 Endogenous Inhibitor of Nitric Oxide Synthaee: 
Differential Effects in Canine Vaeculature 
David G. Cable. Marilyn R. Oeitjen, Hartzell V. Schaff, Mayo Clinic and Mayo Foundation, 
Rochester, Minnesota. 
Background - Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric 
oxide synthase, produced during protein metabolism, but little is known regarding its 
direct vasoactive properties in different arterial beds. 
Methods - Segments of canine coronary, renal, and femoral artedes were pretreated 
with increasing concentrations of ADMA (10-4-10 -6 M), and endothelial function evalu- 
ated in organ chambers. 
Results - In coronary arteries, ADMA inhibited relaxations to acetylcholine but not cal- 
cium ionophore. This inhibition was significant with the highest concentrations of ADMA, 
such that vessels exposed to 10 .4 and 10 .5 M (P<0.001), but not 10 .6 M, ADMA demon- 
strated significant inhibition to endothelium-dependent relaxations to acetylcholine (10 .9. 
10 "s M, n=7) following contraction with prostaglandin F2~(2x10 .6 M). Receptor-indepen: 
dent relaxations to calcium ionophore (10"9-10 "6 M, n=7), however, were not inhibited 
with any concentration of ADMA in canine coronary arteries. The effect of ADMA on ace- 
tylcholine-mediatad relaxations was shown to be competitive inhibition of the nitric oxide 
synthase pathway, as the addition of L-arginine (10 .3 M), but not D-arginine (10 .3 M), 
reversed the effect produced by 10 .5 M ADMA. Further, ADMA did not alter endothelium- 
independent relaxations to sodium nitroprusside (10-9-104 M, n=7). Peripheral arteries 
were more sensitive to ADMA than coronary arteries. Femoral and renal arteries (n=7) 
demonstrated significant ADMA inhibition to receptor-dependent relaxation induced by 
acetylcholine (n=7, P=0.03 and 0.01, respectively) and to receptor-independent relax- 
ations induced by calcium ionophore (n=7, P=0.02 and P=0.01, respectively). 
Concluelone - Altered endothelium-dependent relaxation to asymmetric dimethylargin- 
ine is most marked in femoral and renal, compared to coronary, arteries. This altered 
responsiveness to ADMA in coronary arteries may represent a protective effect in the 
coronary circulation to pathophysiologic states. 
1151-71 Endothelial Function Is Impaired in Treated Depression 
Andrew J. Broadlev. Ania Korzsun, Christopher J. Jones, Michael P. Frenneaux, 
University of Wa/es Col~age of Medicine, Cardiff, United Kingdom. 
Background: Depression is a major world wide health problem and an independent dsk 
factor for coronary heart disease (CHD) events. The mechanism of increased CHD risk is 
unknown. One possibility is endothelial dysfunction (ED), recently demonstrated in 
untreated epression, and a characteristic of other risk factors for CHD such as smoking, 
diabetes, and hypemhotestarolaemia. ED, characterised by impaired flow-mediatad 
release of the vasodilator nitric oxide (NO), is associated with atherogenesis and 
increased CHD events. We measured NO-dependent flow-mediated ilatation (FMD) in 
a group of patients with treated depression and age-matched controls. All subjects were 
free of all other risk factors for CHD. 
Methods: FMD of the brechial artery was assessed using high resolution ultrasound in 12 
patients with treated major depression (mean age 39, range 24 to 51, 6 male) and com- 
pared to that in 9 healthy controls (mean age 37, range 24 to 55, 7 male). GTN-induced, 
endothetium-independent dilatation was also assessed to confirm normal smooth muscle 
responses. 
Results: Values are mean +/- SEM percent brachial artery dilatation. FMD was signifi- 
cantly impaired in the treated depression group compared to the controls (-0.7% +/- 1.7% 
versus 5.9% +/- 1.0%, p = 0.004). In contrast, endothelium-independent dilatation was 
similar in both groups (18.5% +/- 2.4% versus 19.1% +/- 2.5%, p = NS). 
Conclusions: In patients with treated depression who had no other known risk factors for 
CHD, there was ED indicated by absence of FMD. ED with reduced NO activity may be 
the mechanism by which depression increases the risk of CHD. Our data suggest that, 
unlike in hypertension, smoking and hyperoholestarolaemia, ED and increased CHD risk 
may not be reversed by current conventional pharmacological treatment of depression. 
1151-72 Functional Act ivat ion of Inducible Nitric Oxide Synthase 
Closely Related to the Severity of Heart Failure 
Yutaka Ishibashi, Nobuyuki Takahashi, Shuzo Ohata, Shin-ichi Inoue, Yoko Ohta, Harumi 
Katoh, Nobuyuki Oyake, Yo Murekami, Toshio Shimada, Shimane Medical Universi~ 
/zumo, Japan. 
Background: We previously demonstrated that inducible nitric oxide synthase (iNOS) is 
activated in the forearm tissue of patients with congestive heart failure (CHF). In the 
present study we investigated whether the functional activation of iNOS is related with 
the severity of heart failure. 
Methods: We examined the effects of a selective iNOS inhibitor, aminoguanidine (100 
!Jmol/5min), and non-selective NOS inhibitor, L-NMMA (100 i~mol/5min), on forearm 
blood flow (FBF) using venous occlusive plethysmography in 15 patients with CHF and 
10 normal control subjects. In all of these subjects, basel plasma BNP and serum inter- 
leukin 6 (IL-6) levels were measured. Arterial and venous plasma concentrations of 
nitrite/nitrete (NOx) were measured at baseline and after injection of each drug. The 
selectivity of aminoguanidine as a selective iNOS inhibitor was evaluated from FBF 
response during co infusion of acetylcholine and either drug in additional 5 normal sub- 
jects. 
Results: Aminoguanidine significantly attenuated FBF by 15±7% in the patients group, 
however did not alter FBF in the control group. In contrast, L-NMMA significantly reduced 
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FBF in both groups. Arterial NOx concentration was not affected by either drug, however 
venous NOx concentrations were significantly decreased in both the control and patient 
groups by L-NMMA (18±5% and 18±17%, respectively, both p<O.05) and in the patient 
group alone by aminoguanidine (7±6%, p<0.05). The magnitude of effects of ami- 
noguanidine significantly correlated with the concentrations of BNP (r=0.63, p<O.01) and 
IL-6 (r=0.54, p<0.01 ). Acatylcholine-induced vasodilatation was atlenuated by co infusion 
of L-NMMA, but was not by aminoguanidine, suggesting the high selectivity of ami- 
noguanidine as a selective iNOS inhibitor. 
Conclusions: These findings suggested that iNOS is activated in proportion to the sever- 
ity of heart failure, associated with cytokines. 
11 51-73 Impact  of  Different Endothelial Nitric Oxide Synthsee 
Gene Polymorphisms on Endothelium-Dependent 
Vasodilation and Response to Exercise Training in 
Patients With Coronary Artery Disease 
Sandra Eros. Volker Adams, Stephan Gielen, Sven M(Sbius-Winkler, Gerhard Schuler, 
Rainer Hambrecht, University of Leipzig - Heart Center, Leipzig, Germany. 
A polymorphism of the endothelial nitric oxide synthase (eNOS) gene in exon 7 (exon7- 
P) has been well charecterized as a risk factor of coronary artery disease (CAD). An 
aNdS polymorphism in the promotor region (PR-P) was shown to alter eNOS activity. 
Aim of this study was to evaluate the impact of these polymorphisms on the extent of 
endothelial dysfunction in patients (pts) with CAD and on the endothelial response to 
exercise training (ET). 
Fifty-four CAD pts were randomised into a training (4 weeks) or an control group. Aver- 
age peak velocity (APV) in response to acetylcholine (Ach; 7.2 I~g/min) of a coronary or 
the left mammarial artery was invasively assessed by Doppler velocimetry. Exon7-P and 
PR-P were determined by PCR restriction length polymorphism. 
Twenty-six pts were heterozygous and 4 hornozygous for exon7-P (exon7-P+). A het- 
erozygous PR-P (PR-P+) occurred in 14 pts. Ach-induced increase in APV was signifi- 
cantly blunted in exon7-P+ (48±9%) and in PR-P+ (42±8%) compared to 78±9% in wild 
type pts (p<0.05). The presence of both polymorphisms (n=11) resulted in no further 
attenuation of Ach-mediated response (49±6%). 
Conclusion: The presence of the exon 7 and the promotor region eNOS polymorphism in 
CAD pts is associated with a blunted endothelial response to Ach. While exon7-P+ pts 
showed a similar favourable training response at the endothelial level compared to wild 
type pts, pts positive for the PR-P demonstrated an attenuated improvement of Ach- 
mediated vasodilation due to exercise training. 
Effects of ET on APV (* p=0.05 versus wild type and exonT-P.+; # p<0.05 versus 
begin) 
wild type exon 7 + PR + 
Delta APV begin [%] 77±131 34±9 42±8 
Delta APV 4 weeks [%] 131±21 # 87±11 # 80±12 # 
Absolute change in APV 4 weeks versus begin [%} 54±14 53±14 38±14 * 
1151-74 In Vivo Gene Transfer of eNOS and SOD Reduces 
Superoxide Formation in Angiotensin II-Treated Mice 
Hunter C. Chamoion. Trinity J. Bivalacqua, David Kass, Albert L. Hyman, Philip J. 
Kadowitz, Johns Hopkins Hospital, Baltimore, Mary~and, Tu/ane University, Baltimore, 
Maryland. 
Angiotensin It (Ang II) stimulates vascular NADPH oxidase to produce superoxide, which 
can react with nitric oxide and impair vasomotor function. We tested the hypothesis that 
the overexpression of endothelial nitric oxide synthase (eNOS) or superoxide dismutase 
(SOD) would correct angiotensin II-inducad endothelial dysfunction in the hindlimb vas- 
cular bed of the mouse in vivo. We examined the effects of the gene transfer of eNOS or 
2 isoforms of SOD to the hindlimb vascular bed in angiotensin II-treated mice. Mice were 
treated for 2 weeks with Ang II (100 ng • kg-1 • rain-l) or saline infusion. In Ang It-treated 
mice, mean blood pressure was significantly higher when compared to saline-infused 
mice (P<0.05). In aorta and femoral arteries from Ang II-treated mice, lucigenin- 
enhanced chemiluminescence demonstrated a 3-fold increase in superoxide levels, and 
the oxidative fluorescent probe hydroethidine indicated increased superoxide levels 
throughout he vascular wall, especially in the endothelium and adventitia. Hindfimb 
vasodilator responses to the endothelium-dependent agonists acetylcholine, adrenom- 
edullin, and substance P were lower mice treated with angiotensin II when compared to 
saline treated mice. In contrast, endothelium-independent responses to sodium nitro- 
prusside, DENNO, and CGRP were similar in both treatment groups. In vivo gene-trans- 
fer to the hindlimb vascular bed with an edenoviral vector that expressed eNOS, or 
extrecellular SOD (ECSOD) resulted in reduced expression of superoxide and enhanced 
vasodilator responses to the endothelium-dependent vasodilators. In contrast, viral vec- 
tors encoding the reporter gene or copper zinc SOD (CuZnSOD) did not alter superoxide 
expression or vasodilator responses in Ang II-treated mice. These data suggest that 
9ene-transfer of eNOS and EcSOD, but not CuZNSOD, reduces expression of superox- 
ide and restored endothelium-dependent responses in the hindlimb of Ang II-treated 
mice 
1151-75 Family-Based Investigation of the Role of an Endothelial 
Nitric Oxide Synthase Gene Polymorphlsm in Coronary 
Artery Disease 
Mark S. Soence. Paul G. McGlinchey, Chris Patterson, Christine Belton, Gillian Murphy, 
Dorothy McMaster, Pascal P. McKeown, Royal Victoria Hospital, Beffast, United 
Kingdom, Queen's University Belfast, Belfast, United Kingdom. 
Background: Coronary artery disease (CAD) is a complex phenotype arising from the 
interaction of genetic and environmental factors. Nitric oxide (NO) is synthesised in 
endothelial cells from L-arginine and molecular oxygen through the catalytic activity of 
endothelial NO synthase (eNOS) and it is believed to have important atheroprotective 
effects. Functionally important variants of the eNOS (NOS 3) gene could influence indi- 
vidual susceptibility to atherosclerosis by altering the amount of NO generated by the 
endothelium. The G894T (Glu298-Asp) polymorphism of the NOS 3 gene has been 
investigated in several case control studies, with some groups reporting that individuals 
carrying the T aflele are at increased risk of CAD but other groups have not confirmed 
this. 
Aims: Given these conflicting results we have used a family based association test to 
investigate the presence of finkage disequilibrium between the G894T polymorphism of 
the NOS 3 gene and CAD, in a well-defined Irish population. 
Methods: A total of 501 individuals (189 families) were recruited comprising 29 trios 
(individual affected with premature CAD and both parents) and 266 discordant sibships 
(one sibling affected with premature CAD and one older unaffected sibling). Premature 
CAD in our population was defined as onset before the age of 55 years in males and 
before the age of 60 years in females. All were genotyped for the G894T polymorphism 
of the NOS 3 gene. The presence of linkage disequilibrium was investigated using the 
combined transmission disequilibrium test (TDT) / sib TDT. This test is unaffected by 
population admixture and is specifically designed for the investigation of complex dis- 
eases. We tested for excess transmission of the G or T allele to affected individuals. Only 
one discordant sibship or trio was inctuded from each family to ensure the analyses were 
a valid test of association. 
Results: There was no statistically significant excess transmission of either allele to 
affected individuals, (p=0.20). 
Conclusion: Using newly developed family-based association methods we have found 
no evidence that the G894T (Glu298-Asp) polymorphism of the NOS 3 gene is associ- 
ated with CAD in our study population. 
1151-76 Elevated Glucose Increases ADMA: Role of Oxidative 
Stress and DDAH 
Ken Y. Lin, Bing Y. Wang, Philip S. Tsao, John P. Cooke, Cardiovascular Medicine, 
Stanford University School of Medicine, Stanford, California. 
Background: An endogenous inhibitor of nitric oxide synthase, asymmetric dimethylargi- 
nine (ADMA) is elevated in diabetic patients. Oxidative stress is also a hallmark of diabe- 
tes mellitus. We sought to determine if elevated glucose increased ADMA by impairing 
the activity of the enzyme dimethylarginine dimethylaminohydrolase (DDAH), which 
metabolizes ADMA to citrulline. We further determined if the dysfunction of DDAH was 
due to oxidative stress. 
Methods: Human microvessel endothelial cell lines were cultured in normal (5 mM D- 
glucose), or high glucose conditions (25 mM D-glucose); in some experiments, mannose 
(20mM), or polyethyleneglycol-conjugated superoxide dismutase (PEG-SOD, 22u/mL) 
were added. ADMA production was measured by HPLC; cGMP by ELISA; DDAH activity 
by ADMA turnover ate. 
Results: ADMA was significantly elevated in the high glucose condition (2.21±0.21 I~M/ 
107 cells; p < 0.05) as compared to cells cultured in normal concentration of glucose 
(1.44±0.14). Mannose (as an osmotic control) had no effect on ADMA levels. PEG-SOD 
reduced ADMA levels to baseline in the high glucose condition (1.32±0.20). Reflecting 
bioavailable nitric oxide, cGMP production was significantly less in cells exposed to high 
glucose (74.8±6.4 frnol/mg protein; p < 0.05) than cells cultured in normal glucose or 
mannose (95.8±4.5 or 91.3±3.2); PEG-SOD restored cGMP levels in the high glucose 
condition (101±3.7 fmoVmg protein). DDAH activity was significantly reduced in high glu- 
cose (31.5±5.1%; p < 0.05) and was restored by PEG-SOD addition (38.8±3.3%) to a 
level comparable to cells exposed to normal glucose or mannose (40.2_+3.8% and 
42.5+_2.6%, respectively). 
Conclusions: Hyperglycemia elevates oxidative stress, which impairs DDAH activity, 
causing an increase in ADMA to reduce nitric oxide synthesis. This observation repre- 
sents a new insight into diabetes-induced endothelial dysfunction. 
